BackNuvectis Pharma Overview

Nuvectis Pharma Total Assets

Latest total assets for NVCT: $140M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$140.84M
↑ 295.76% YoYΔ $105.25M vs prior year quarter

Peer trimmed avg / median

Loading

Nuvectis Pharma Total Assets History

Loading

Nuvectis Pharma vs. peers: Total Assets Comparison

Loading

Nuvectis Pharma Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Nuvectis Pharma (NVCT) FAQ

Nuvectis Pharma (NVCT) currently reports a total assets of $140M as of September 2026. That compares with $36M in the prior-year period — up 295.8% year over year. Use the charts on this page to explore Nuvectis Pharma's total assets history and peer comparisons.

Nuvectis Pharma's total assets increased from $36M to $140M — a 295.8% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nuvectis Pharma reported $140M in total assets as of September 2026. That compares with $36M in the prior-year period — up 295.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $140M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nuvectis Pharma, and consider following NVCT for alerts when major investors trade the stock.